The molecular pathways controlling cerebellar Purkinje cell dendrite formation and maturation are poorly understood. The Purkinje cell degeneration (pcd) mutant mouse is characterized by mutations in Nna1, a gene discovered in an axonal regenerative context, but whose actual function in development and disease is unknown. We found abnormal development of Purkinje cell dendrites in postnatal pcd Sid mice and linked this deficit to a deletion mutation in exon 7 of Nna1. With single cell gene profiling and virus-based gene transfer, we analyzed a molecular pathway downstream to Nna1 underlying abnormal Purkinje cell dendritogenesis in pcd Sid mice. We discovered that mutant Nna1 dramatically increases intranuclear localization of lysyl oxidase propeptide, which interferes with NF-kB RelA signaling and microtubule-associated protein regulation of microtubule stability, leading to underdevelopment of Purkinje cell dendrites. These findings provide insight into Nna1's role in neuronal development and why its absence renders Purkinje cells more vulnerable.
INTRODUCTION
Cerebellar Purkinje cells are central neurons controlling motor learning and coordination. Many fundamental concepts of modern neuroscience have been established by a focus on these vividly constructed cells (Rossi and Tempia, 2006) . Three unique features make Purkinje cells a valuable model for the discovery of mechanisms underlying neuronal development and degeneration. First, Purkinje cells develop postnatally the most elaborate dendritic trees of all neurons in the human and rodent brain (Kapfhammer, 2004) . Second, Purkinje cells are the most vulnerable neurons in various neurological diseases ranging from genetic defects to acquired injury or poisoning and from autism to Alzheimer's (Sarna and Hawkes, 2003) . Third, Purkinje cells often undergo dendritic malfunction and cell death in circumstances that may cause lesser, but still debilitating, damage in other areas of the brain (Sirzen-Zelenskaya et al., 2006) .
Because dendritogenesis is a key process in Purkinje cell development, essential for establishment of cerebellar circuitry, it is important to determine how developing Purkinje cell dendrites acquire their characteristic size and morphology (Wong and Ghosh, 2002) . Development of Purkinje cell dendrites in postnatal cerebellum can be divided into two successive, tightly regulated stages. In the first postnatal week, bipolar fusiform Purkinje cells retract their primitive processes and extend numerous short perisomatic protrusions. In the second and third postnatal weeks, Purkinje cells form a primary dendrite and undergo rapid dendritic elongation and branching in the sagittal plane to elaborate their typical dendritic tree (Sotelo and Dusart, 2009) . Although a number of genetic and environmental factors relate to cytoskeletal organization in Purkinje cells (Shima et al., 2004) , the molecular pathways controlling dendrite formation and maturation, in contrast to axonogenesis, are poorly understood (Poulain et al., 2008) . Purkinje cell dendrites are also abnormal in many diseases by mechanisms yet to be elucidated (Becker et al., 2009 ).
Here we characterized the Purkinje cell degeneration (pcd) mutant, pcd Sid and uncovered an exon 7 deletion in Nna1 (neuronal nuclear protein induced by axotomy). We then identified upregulated lysyl oxidase (Lox) as a candidate molecule for dendritic underdevelopment of young pcd Sid Purkinje cells.
Lox is an extracellular copper enzyme that catalyzes conversion of lysine residues to aldehydes in collagen and elastin precursors, contributing to extracellular matrix formation and repair (Lucero and Kagan, 2006 (A) Compared to wild-type (wt) mouse, adult P120 pcd Sid mutant was smaller and showed motor incoordination.
(B) Hematoxylin and eosin (H&E)-stained sagittal section showed an atrophic cerebellum in P120 pcd Sid mutant. Scale bar represents 500 mm.
(C) Neuron-specific nuclear protein (NeuN)-stained granule cells (red) in the granular layer (GL) were slightly decreased, whereas the molecular layer (ML) was obviously reduced in P120 pcd Sid cerebellar cortex. DAPI stained cell nuclei (blue). Scale bar represents 50 mm.
(D) Calbindin (Calb)-stained Purkinje cells (red) were totally lost in P60 pcd Sid cerebellar cortex. Scale bar represents 50 mm.
cutaneous systems; and Lox-deficient mice die perinatally (Mä ki, 2009) . Although Lox increases in injured rat brain (Gilad et al., 2001) , mutant SOD1 transgenic mouse brain (Li et al., 2004 ) and Alzheimer's disease human brain (Gilad et al., 2005) , its modes of action in the central nervous system (CNS) are almost unknown. With a set of complementary approaches, including primary Purkinje cell and organotypic slice cultures, neonatal cerebellar cortex injection, lentiviral vector-based cDNA or shRNA transduction, enzyme dynamics and dendritic tree quantification, we defined a molecular pathway leading to the dendritic underdevelopment. In this pathway, the Nna1 mutation increases localization of Lox propeptide (a Lox fragment without enzymatic activity) in Purkinje cell nuclei, followed by inhibition of NF-kB RelA signaling, which further decreases microtubule-associated protein (MAP) 1B and MAP2, eventually suppressing Purkinje cell dendritic growth. NF-kB and MAPs were reported to regulate neuronal process outgrowth and migration (Gutierrez et al., 2005; Teng et al., 2001 ), and we further dissected their roles in postnatal development of Purkinje cell dendrites. This Loxbased metabolic pathway affects dendritogenesis, without an apparent effect on Purkinje cell viability.
RESULTS

Characterization of the Nna1 Mutation and Purkinje Cell Pathogenesis in pcd
Sid Mutant Mice A spontaneous mutation was discovered in two mice in a litter of presumed wild-type BALB/c mice purchased from Charles River Laboratories. Ataxic progeny appeared in crosses of unaffected siblings with pcd 1J mice, and further breeding and histopathological analyses established that the mutation was allelic with pcd. It was named according to standard nomenclature procedures as pcd Sid and has been maintained congenic with the C57BL/6J strain for more than 25 generations. Homozygous pcd Sid mutants showed reduced width of the cerebellar molecular layer and death of most Purkinje cells ( Figures 1A-1I ), resulting in severe ataxia, as in the previously described mutant alleles, pcd 2J-4J (see Figures S1A-S1F available online) (Wang and Morgan, 2007) . In pcd Sid cerebella, all
Purkinje cells were lost in lobules I-VIII between postnatal days 21 (P21) and P30, whereas some Purkinje cells in lobules IX-X survived for additional weeks. Unequivocal identification of pcd Sid as an allele at the Nna1 locus came from our evidence of an Nna1 exon 7 deletion in cerebrum and cerebellum of pcd Sid mutants, producing a stop codon in exon 8 (Figures 1J and 1K;  Table S1 ). In addition, we characterized a six-nucleotide insertion between exons 6 and 7 of Nna1 in pcd 4J brains (Figures S1G and S1H) , in which a lysine at amino acid 176 was replaced by an isoleucine-lysine-glutamic acid tripeptide. Affected progeny also appeared in crosses between pcd 3J and pcd 4J heterozygotes.
To dissect the pathological process, we examined young pcd Sid Purkinje cells before the onset of neuronal death and ataxia. In matings of pcd Sid heterozygotes, P14 homozygous pcd Sid progeny were distinguished from their heterozygous and wild-type littermates by accumulation of basal polyribosomes in Purkinje cell bodies ( Figure 1L ), suggesting early abnormalities in protein synthesis and processing (Landis and Mullen, 1978) . In P20 pcd Sid cerebellum, many Purkinje cells exhibited fewer dendritic branchlets in the molecular layer ( Figure 2F ), while some already showed the nuclear condensation and cytoplasmic shrinkage typical of apoptotic cell death ( Figure 1M ) (Dusart et al., 2006) . These findings suggest that the Nna1 mutation in pcd Sid may affect downstream molecules involved in at least three major functions: protein metabolism, dendritic growth, and apoptosis.
Identification of Molecules Downstream from Mutant Nna1 in pcd Sid Purkinje Cells
The pcd disorder was recognized as Purkinje cell-autonomous by analysis of wild-type/pcd chimeras (Mullen, 1977) , but available gene expression data in pcd mutants are neither comprehensive (Kyuhou et al., 2006) nor specific for affected Purkinje cells (Ford et al., 2008 Figure 2A) . As verified by quantitative real-time PCR (qPCR) (E) The Purkinje cell body layer (PL) disappeared, and the ML was shrunk in P60 pcd Sid cerebellar cortex. Scale bar represents 25 mm.
(F) Parvalbumin (Parv)-stained interneurons (red) in the ML showed no obvious changes, whereas Parv-stained Purkinje cell bodies at the PL disappeared in P60 pcd Sid cerebellar cortex. Scale bar represents 50 mm. and gel identification ( Figure 2B ; Table S3 ), we discovered three candidate molecules, Calr3 (calreticulin 3), Lox, and Bim (Bcl2-like 11), to be dramatically upregulated >50-fold ( Figures 2C  and 2D ). Because Calr3 is a molecular chaperone involved in protein synthesis and processing (Bedard et al., 2005) , and Bim functions as a neuronal apoptosis facilitator (Greene et al., 2007) , the upregulation of Calr3 and Bim expression may be responsible, respectively, for abnormal protein metabolism ( Figure 1L ) and neuronal death ( Figure 1M ) in young pcd Sid mutants, leading to Purkinje cell death ( Figure 2G ). Thus, in the present study, we have addressed a probable role of excess Lox in regulating postnatal growth of Purkinje cell dendrites. By measuring spatial and temporal expression of Lox with qPCR, we found Lox mRNA levels (over the base line at 2% of Gapdh) to be detectable in most areas of wild-type mouse embryonic CNS, in 50% of the sampled areas of P7 CNS, and in fewer areas of adult CNS ( Figure S2D ), suggesting that Lox expression decreases with CNS development and maturation. With western blot and immunohistochemistry, we also found Lox protein levels to be relatively low in P7-P20 wildtype cerebella, but increased in P20 pcd Sid cerebella ( Figure 2E ) and Purkinje cells ( Figure 2F ), concurrent with the reduced dendritic branching ( Figure 2F ). Importantly, the above changes were also found in pcd 2J mutants (Figures S1I-S1K).
Suppression of Purkinje Cell Dendritic Growth In Vitro by Nna1 shRNA or Lox cDNA
We set up mixed cultures of primary cerebellar cells from P0 mouse pups ( Figure S3A ), in which cultured Purkinje cells came to resemble postnatal Purkinje cells in vivo by forming dendritic branchlets (Figures 3A and 3B) through two stages (Tabata et al., 2000) . To establish an in vitro model of the pcd Purkinje cell pathological process, we transduced wild-type cerebellar cell cultures with lentiviral vector-based Nna1 shRNA (Table S5 ) from 7 to 14 days in vitro (DIV), and found that Nna1 RNA interference (RNAi) significantly suppressed Purkinje cell dendritic growth at 14 DIV ( Figures 3C and 3D ) and increased Purkinje cell death at 21 DIV ( Figure S3B ). We also cotransduced cerebellar cell cultures with both Nna1 shRNA and Lox shRNA (Table S5) , and found that Lox shRNA greatly rectified Nna1 RNAi-reduced Purkinje cell dendritic growth ( Figures 3C and  3D ), but did not prevent Nna1 RNAi-triggered Purkinje cell death ( Figure S3B ). These results suggest that Lox plays a role in pcd Purkinje cell dendritic development, but is less important in pcd Purkinje cell death.
To verify the possible relationship between increased Lox and abnormal dendritic development, we treated cerebellar cell cultures with suramin, a Lox expression stimulator (Buchinger et al., 2008) , and found that suramin suppressed Purkinje cell dendritic growth (Figures 3E and 3F) . We then transduced cerebellar cell cultures with lentiviral vector-based Lox cDNA ( Figure S3C and Table S5 ) from 2 to 7 DIV (the early stage), or from 7 to 14 DIV (the later stage), and found that Lox cDNA significantly reduced Purkinje cell perisomatic sprouting at the early stage ( Figure S3D ) and Purkinje cell dendritic arborization at the later stage (Figures 3E and 3F ; Figure S3E ), which were rectified by Lox shRNA ( Figures 3E and 3F ). The efficiency of Lox cDNA or Lox shRNA transduction was confirmed by Lox protein assay in either cultured cells or culture medium (Figure 3G ). These results suggest that increased Lox expression in cerebellar cell cultures may interfere with Purkinje cell dendritic growth at both early and later stages.
We next set up cerebellar organotypic slice cultures (Li et al., 2006a (Li et al., , 2006b ) from P7 mouse pups (Figure S4A ) to analyze later stages of Purkinje cell dendritic growth (Figures 4A and 4B) and viability ( Figure S4B ). We found that treatment with suramin or Lox cDNA from 0 to 7 DIV (P7 + 7 DIV = 14 days) and from 10 to 14 DIV (P7 + 14 DIV = 21 days) greatly suppressed Purkinje cell dendritic growth (Figures 4C and 4D; data not shown). These effects on Purkinje cell dendrites could be rectified by Lox shRNA (Figures 4C and 4D) , and were coincident with our finding that Lox upregulation in vivo was accompanied by underdevelopment of P20 pcd Purkinje cell dendrites ( Figure 2F ; Figures S1I and S1K).
Verification of Lox cDNA Effects on Purkinje Cell Dendritic Development In Vivo
Viral vectors carrying the L7 promoter are useful for selective expression of a foreign gene in Purkinje cells in vivo, but this promoter's low transcriptional efficiency and large size limit its value for transduction (Takayama et al., 2008) . Lentiviral vectors have a larger insert capacity, elicit no or minimal inflammatory response, and integrate genes into target cell chromosomes, leading to stable long-term expression (Hirai, 2008; Torashima et al., 2006) . To avoid an inhibitory effect on Purkinje cell dendrites caused by a strong MSCV (murine stem cell virus) promoter (Sawada et al., 2010) , we prepared lentiviral vectorbased gene constructs carrying the weaker CMV (cytomegalovirus) promoter (Table S5 ). These constructs themselves did not change Purkinje cell dendrite morphology in vivo ( Figure 5E ).
To study whether excess Lox affects postnatal development of Purkinje cell dendrites in vivo, we injected Lox cDNA tagged with eGFP, control eGFP cDNA, or control vehicle into the cerebellar cortices of P7 wild-type mice ( Figure S5A and Table S5 ). As expected, the locally transduced Purkinje cells displayed green fluorescence ( Figure S5B ), and Lox cDNA significantly suppressed development of Purkinje cell dendrites examined at P14 and P21 ( Figures 5A-5E ). However, this inhibitory effect on dendritic development did not lead to the Purkinje cell death ( Figures S5C and S5D) , characteristic of pcd mutants (E) Western blot showed very low levels of Lox protein in P7, P10, P15, and P20 wild-type cerebella and an increased level in P20 at P21-P28. Lox cDNA and control cDNA also transduced a small number of granule cell precursors, stellate or basket interneurons, and Bergmann glial cells, but these cells did not show (B) Representative schematic Sholl diagram showed parameters of node (green dot), end (orange dot) and dendrite (blue dot) for quantification of Purkinje cell dendritic trees. The distance between adjacent concentric circles was 10 mm. of enriched granule cells or conditioned medium (Figures 6A and 6B) , suggesting that overexpressed Lox may affect Purkinje cell dendritic growth in a cell-autonomous manner, independent of neighboring granule cell actions and factors in the conditioned medium.
To check whether the inhibitory effect of excess Lox on Purkinje cell dendritic growth is related to Lox enzymatic activity, we treated cerebellar cell cultures with various Lox enzyme regulators. We verified that copper (a Lox enzymatic activator) and Lox cDNA increased Lox enzymatic activities ( Figure 6C ), whereas bathocuproinedisulfonate (BCS, an inhibitor of extracellular Lox activity) and b-aminopropionitrile fumarate (BAPN, an inhibitor of both extracellular and intracellular Lox activity) (Erler et al., 2006 ) not only inhibited Lox enzymatic activities, but also restored Lox cDNA-increased enzymatic activities ( Figure 6C ). However, neither copper nor BCS and BAPN changed the morphology of Purkinje cell dendritic trees, or prevented Lox cDNA-suppressed Purkinje cell dendritic growth ( Figures 6D and 6E ). These findings were also confirmed in wild-type cerebellar slice cultures ( Figures 4C and 4D ). Thus, we found no significant correlation between Lox enzymatic activity and Purkinje cell dendritic growth ( Figure 6F ).
Furthermore, we treated pcd Sid ( Figures 4C and 4D ) and pcd
2J
( Figures S4C and S4D Figure S4G ) and glial cells ( Figure S4H ) did not differ among the various treatments. These slice culture experiments verify our findings with the cerebellar cell cultures, i.e., Lox RNA knockdown, rather than Lox enzymatic inhibition, can rectify Nna1 mutation-or Nna1 shRNA-suppressed Purkinje cell dendritic development, but this does not prevent pcd Purkinje cell death.
Excess Lox Propeptide in Purkinje Cell Nuclei Is Responsible for Purkinje Cell Dendritic Underdevelopment
We next looked more deeply into the basis for the effect on Purkinje cell dendritic development by analyzing Lox propeptide. Lox is synthesized as a 50 kDa precursor, secreted into the extracellular matrix, and subsequently catabolized to a 30 kDa mature enzyme fragment from the C-terminal moiety and an 18 kDa propeptide fragment without enzymatic activity from the N-terminal region (Lucero and Kagan, 2006) . Extracellular Lox propeptide is arginine-rich, and readily taken up by cells due to its unusually high isoelectric point of 12.5 (Palamakumbura et al., 2004) . We transduced cerebellar cell and slice cultures with lentiviral vector-based Lox propeptide cDNA (Table S5) , whose efficiency was confirmed by Lox propeptide protein assay ( Figure 6G ). We found that Lox propeptide cDNA by itself did not change Lox enzymatic activity ( Figure 6C ), but like Lox cDNA, did suppress Purkinje cell dendritic growth in both cerebellar cell ( Figures 6D and 6E ) and slice ( Figures 4C  and 4D ) cultures. These results confirm that excess Lox or Lox propeptide suppresses Purkinje cell dendritic growth by mechanisms unrelated to Lox enzymatic activity. Because Lox and Lox propeptide are known to display stage-dependent distribution in various organelles of osteoblasts (Guo et al., 2007) , we measured Lox and Lox propeptide distribution in Lox cDNA-or Lox propeptide cDNA-transduced Purkinje cells, where dendritic growth was suppressed. The two primary antibodies we used were an antibody against the C-terminal segment of Lox for detecting entire Lox or Lox enzyme, and a Lox propeptide antibody against the N-terminal segment for detecting entire Lox or Lox propeptide. We found that no signals could be detected by either antibody in control Purkinje cells ( Figure 6H ). When Purkinje cells were transduced by Lox cDNA, the signals were detected in nuclei, cell bodies and dendrites by the Lox enzyme antibody, and were detected in nuclei and cell bodies by the Lox propeptide antibody (Figure 6H ). When cells were transduced by Lox propeptide cDNA, the signals were detected predominantly in nuclei by only the Lox propeptide antibody ( Figure 6H ). These findings indicate that excess Lox propeptide protein is concentrated in Purkinje cell nuclei, a site for gene transcriptional regulation.
Nna1 shRNA or Lox Propeptide cDNA Suppresses Purkinje Cell Dendritic Growth via Reduced RelA
Lox and Lox propeptide were reported to suppress cancer cell transformation (Palamakumbura et al., 2004) or vascular smooth muscle cell proliferation (Hurtado et al., 2008 ) via inhibition of NF-kB signaling. Because NF-kB regulates neuronal process outgrowth (Gutierrez et al., 2005) and synaptic function (Meffert et al., 2003) , we hypothesized that the inhibitory effect of excess Lox propeptide on Purkinje cell dendrites might be mediated by abnormal NF-kB signaling. Our microarray and qPCR data showed that RelA, a major member of the NF-kB family, was significantly downregulated in LCM-isolated pcd Sid Purkinje cells (Figures 2A and 2B ). We also measured three components (Table S3 ) of the NF-kB family in Nna1 shRNA-, Lox cDNA-, or Lox propeptide cDNA-transduced cerebellar cell cultures, and found that mRNA and protein levels of NF-kB RelA were greatly decreased, whereas NF-kB p50 and IkBa were not significantly changed ( Figures 7A and 7B) . Importantly, we observed that Lox RNAi could rectify Nna1 shRNA-induced NF-kB RelA reduction ( Figures 7A and 7B) . We next checked effects of diverse Nna1 and RelA treatments on Lox levels, and found that Nna1 shRNA, rather than RelA cDNA or shRNA, significantly increased Lox mRNA levels in cultured Purkinje cells ( Figure 7C ). Also, neither RelA cDNA nor shRNA rectified the Nna1 shRNA-induced Lox mRNA upregulation ( Figure 7C ). The efficiency of RelA cDNA or shRNA transduction was verified by RelA protein assay ( Figure 7D ). Furthermore, both Lox and RelA manipulation did not change Nna1 expression (data not shown).
RelA contains a transactivation domain that is required for transport of the active NF-kB complex into cell nuclei. In contrast, p50 lacks this domain and must form heterodimers with RelA to translocate into cell nuclei. We observed by immunohistochemistry and confocal microscopy that intranuclear RelA was much lower in P20 pcd Sid mutant Purkinje cells than in wild-type controls in vivo ( Figure 7E ). With DNA-binding ELISA
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Control of PC Dendrite Genesis by Lox and RelA assays we measured NF-kB activation in Purkinje cell nuclei, and found that RelA overexpression increased only RelA transactivation ( Figure 7F ), but not p50 transactivation ( Figure 7G ), whereas RelA downregulation by Nna1 shRNA, Lox cDNA, Lox propeptide cDNA, or RelA shRNA significantly inhibited both RelA ( Figure 7F ) and p50 ( Figure 7G ) transactivation. We found further that RelA downregulation suppressed Purkinje cell dendritic growth (Figures 7H and 7I) . To detect whether abnormal RelA mediated excess Lox-suppressed dendritic growth of Purkinje cells, we treated Lox cDNA-transduced cerebellar cell cultures with an NF-kB activator, tumor necrosis factor-a (Royuela et al., 2008) , and found that this factor significantly protected Purkinje cell dendritic trees (data not shown). In addition, although RelA cDNA by itself did not obviously alter Purkinje cell dendritic morphology (Figures 7H and 7I) , it did rectify Nna1 shRNA-or Lox propeptide cDNAsuppressed Purkinje cell dendritic growth ( Figures 3C, 3D , 6D, 6E, 7H, and 7I), suggesting that NF-kB RelA downregulation mediated the inhibitory effects of Nna1 RNAi or Lox propeptide overexpression on dendritic growth of developing Purkinje cells.
Abnormal NF-kB Signaling Alters MAPs Controlling Purkinje Cell Dendritic Growth
Microtubules composed of tubulin subunits are major cytoskeletal components running longitudinally in neuronal processes, and MAPs bind to tubulin subunits to control microtubule stability. MAP-microtubule binding is regulated by microtubule affinity regulating kinase (MARK) with phosphorylation detaching MAP from microtubules. We detected a significant downregulation of MAP1B mRNA and MAP2 mRNA, and an upregulation of MARK3 mRNA in LCM-isolated Purkinje cells of P20 pcd Sid mutants ( Figure S6A ). Both MAP1B and MAP2 are expressed predominantly in Purkinje cell dendrites, relative to Purkinje cell axons (Chauhan and Siegel, 1997) . The double knockout of MAP1B and MAP2 has synergistic effects on neuronal migration, dendritic growth and microtubule organization (Teng et al., 2001) . We examined spatial and temporal distribution of microtubule and MAP proteins in postnatal cerebella by immunohistochemistry, and found obvious decreases of MAP1B, MAP2, and tubulin bIII in the molecular layer of P20 pcd Sid cerebellar cortices ( Figure 8A ). We next measured MAP1B and MAP2 in cerebellar cell cultures that had been transduced by Nna1 shRNA, Lox cDNA, Lox propeptide cDNA, or RelA shRNA, and found that these lentiviral vector-mediated transductions inhibited MAP1B and MAP2 levels in Purkinje cell dendritic branches ( Figure 8B ). Furthermore, we found by quantitative analysis that Lox shRNA or RelA cDNA rectified Nna1 RNAireduced MAP1B, whereas RelA cDNA rectified Lox or Lox propeptide cDNA-reduced MAP1B ( Figure S6B ). These results indicate that changes in microtubule and MAP levels are associated with Purkinje cell dendritic underdevelopment in postnatal pcd cerebellar cortices in vivo and in Nna1 shRNA-treated cerebellar cell cultures.
To establish a causal relationship between abnormal MAP levels and Purkinje cell dendritic underdevelopment, we transduced cerebellar cell cultures with MAP shRNA and cDNA. Neither MAP1B shRNA nor MAP2 shRNA alone changed Purkinje cell dendritic trees, but a joint application of the two shRNAs significantly suppressed Purkinje cell dendritic growth ( Figures 8C and 8D) . In contrast, either MAP1B cDNA or MAP2 cDNA individually rectified RelA shRNA-suppressed Purkinje cell dendritic growth ( Figures 8C and 8D ). These data are consistent with a previous report (Teng et al., 2001) , suggesting a functional redundancy between MAP1B and MAP2, and a synergistic effect of their double deficiency on Purkinje cell dendritic growth. Our findings disclose that abnormal MAP1B and MAP2 mediate the underdevelopment of Purkinje cell dendrites triggered by Nna1 mutation, Lox-propeptide cDNA, or RelA shRNA.
DISCUSSION
In this study, we characterize a pcd mutant allele, pcd Sid that shows postnatal Purkinje cell death and severe ataxia due to the deletion of Nna1 exon 7. We correlate increased Lox with underdevelopment of pcd Sid Purkinje cell dendrites before neuronal death, and dissect a molecular pathway ( Figure 8E ) in which the Nna1 mutation upregulates Lox and increases Lox propeptide in Purkinje cell nuclei. The excess Lox propeptide inhibits NF-kB RelA signaling and MAP roles in Purkinje cell dendritic growth. We formulate this molecular pathway based on several findings. First, the Nna1 mutation increases Lox, reduces RelA and MAPs, and suppresses Purkinje cells dendritic growth in vivo and in vitro, supporting that Lox, RelA, and MAPs are downstream from Nna1. Second, although excess Lox reduces RelA, manipulation of RelA does not alter Lox levels, suggesting that RelA is downstream from Lox. Third, RelA shRNA alters MAPs and suppresses Purkinje cell dendritic growth, whereas MAP cDNA blocks the inhibitory effects of RelA shRNA on Purkinje cell dendritic growth, an indication that MAPs are downstream from NF-kB RelA signaling. The pcd mouse model (Wang and Morgan, 2007) , one of the first among the presently identified 50 mutation-induced cerebellar ataxias, includes a group of autosomal recessive mutations in the Nna1 gene, pcd Babe, Btlr, Tg . We present two previously undescribed Nna1 mutations: a deletion of the entire exon 7 in pcd Sid , and a six-nucleotide insertion between We not only identify upregulated candidate molecules such as Calr3, Lox, and Bim for abnormal protein synthesis, dendritic underdevelopment, and apoptosis, respectively, but also disclose additional potential markers for Purkinje cells and granule cells (Table S2 ). Lox has been widely described to have multiple roles in formation and repair of extracellular matrix (Lucero and Kagan, 2006) , in development of cardiac, pulmonary and cutaneous tissues (Mä ki, 2009; Rodríguez et al., 2008; Szauter et al., 2005) , and in tumor progression and metastasis (Erler et al., 2006; Payne et al., 2007) . Although Lox levels are increased in selected types of diseased brains in rodents and humans (Gilad et al., 2001 (Gilad et al., , 2005 Li et al., 2004) , its role in the CNS is unknown. Here, we describe a pathological role of excess Lox in the CNS, particularly in Purkinje cell dendritic development. We show that the remarkably upregulated Lox levels in pcd Sid Purkinje cells are concurrent with pcd Sid Purkinje cell dendritic underdevelopment, and that excess Lox negatively regulates dendritic arborization of developing Purkinje cells in cerebellar cell or slice cultures and in the cerebellar cortex in vivo.
Most of the previously reported effects of Lox involve its copper-utilizing enzymatic activity, particularly on extracellular collagen and elastin. In contrast, nonenzymatic Lox propeptide suppresses prostate (Palamakumbura et al., 2009) , breast , lung, and pancreatic (Wu et al., 2007) cancer cells. We observe that Purkinje cell dendritic growth is suppressed by excess Lox via mechanisms independent of its enzymatic activity, for Lox enzymatic inhibitors do not rectify actions of Lox overexpression, and Lox propeptide (lacking Lox enzymatic activity) has a similar action to enzymatic Lox. Thus, our study prompts a new research direction on this important molecule.
Lox propeptide inhibition of cancer cell transformation and tumor formation is associated with NF-kB and other signaling pathways Palamakumbura et al., 2009; Wu et al., 2007) . In the CNS, nuclear translocation and gene activation of transcription factor NF-kB regulate neuronal processes (Gutierrez et al., 2005) and synapses (Meffert et al., 2003) . We find that excess Lox propeptide suppresses Purkinje cell dendritic growth also via the NF-kB signaling pathway. RelA, a major member of the NF-kB family and a positive regulator of neuronal process growth, shows reduced expression and less nuclear translocation in pcd Sid Purkinje cells in vivo. A role for RelA in this dendritic development pathway is also consistent with the observed downregulation of RelA expression and inhibition of RelA transactivation by Nna1 shRNA or Lox propeptide cDNA in cerebellar cell cultures. Exogenous expression of RelA can block the suppression of Purkinje cell dendritic growth due to excess Lox propeptide. Our data further show that RelA knockdown alters MAP1B and MAP2, two key regulators of Purkinje cell dendritic development.
MAPs promote assembly of tubulin, bind and stabilize microtubules, and form cross-bridge structures between microtubules. MAP1B and MAP2 are among the most abundant neuronal MAPs, and play important roles in neuronal morphogenesis. We confirm that MAP1B and MAP2 are expressed predominantly in Purkinje cell dendrites, relative to Purkinje cell axons (Chauhan and Siegel, 1997) . These two MAPs show functional redundancy, because mice with double knockouts, but not with either single knockout, show inhibited dendritic growth (Teng et al., 2001) . We also establish a causal relationship between MAP1B/MAP2 and Purkinje cell dendritic growth by MAP knockdown and overexpression. Thus, our study describes a molecular pathway composed of mutant Nna1, excess Lox qPCR and Nucleotide Sequencing SYBR Green I-based qPCR was carried out with a DNA engine opticon continuous fluorescence detection system. For normalization of each sample, GAPDH primers were used to measure the amount of GAPDH cDNA. The data were presented as ratios of measured gene/GAPDH. Some PCR products were verified with 1% agarose gel. Nucleotide sequence of Nna1 cDNA was analyzed at the BIDMC Sequencing Facility. Samples were electrophoresed, detected, and analyzed on a PE/ABI 377 DNA sequencer. Sequence data were analyzed with Gene Runner software and the BLAST program.
Cerebellar Cell and Slice Culture
Mixed cerebellar cells or enriched Purkinje cells from P0 C57BL/6J mouse pups were cultured in serum-free medium for 7-21 DIV; and cerebellar organotypic slices from P7 mouse pups were cultured in serum-containing medium for 7-14 DIV. The cultures were treated with various factors at designated times. Specific antibodies were used to assess Purkinje cell survival, dendritic branchlets, and other cerebellar cells.
Lentiviral Vector-Based cDNA or shRNA Transduction Omicslink expression construct (GeneCopeia), pReceiver-Lv08 with CMV promoter, was used for packaging, transduction, and stable integration of Lox, Lox-propeptide, RelA, MAP1B, or MAP2 cDNA into genomic DNA of cerebellar cells. Mission lentiviral transduction particles (Sigma) containing pLKO.1-puro expression construct with U6 promoter were used to transduce Nna1, Lox, RelA, MAP1B, or MAP2 shRNA into cerebellar cells.
Quantification and Statistic Analysis
Number and proportion of the specific (calbindin, Lox, or others) staining positive-and negative-cells were counted from cerebellar cell and slice cultures in vitro, or stereologically quantified from a series of representative sequentially-cut cerebellar sagittal sections (40 mm) in vivo. Single Purkinje cells in cerebellar cell cultures and grouped Purkinje cells in cerebellar slice cultures or the cerebellar cortices (lobules V-VIII) in vivo were randomly selected and imaged by confocal microscopy (Zeiss Axiovert 100M) with a 633 oil objective under optimal conditions (laser power, background, and signal threshold). Z series images for each sample acquired by 1 mm optical sectioning were projected onto a 2D image file, and the complete dendritic RelA arborization of Purkinje cells was traced and analyzed with Neurolucida software (MicroBrightField Bioscience). The parameters for dendrite quantification included node number, end number, dendrite length, and dendrite distribution (Sholl analysis). The data were presented as the parameter per Purkinje cell in cell cultures (without dendritic tree overlapping between adjacent cells), or as the parameter per field in slice cultures or the cerebellum in vivo (with dendritic tree overlapping between adjacent cells). ImageJ software (NIH) was used to quantify immunofluorescence staining images. Quantity I software was used for the quantitative analyses of cDNA and protein bands on gel or film. Comparison between groups, either paired or unpaired as required, was carried out with (1) analysis of variance (ANOVA) and the Student's t or t 0 test (according to results of the homoscedasticity analysis)
for the measurement data; (2) the c 2 test for enumeration data; (3) the linear or nonlinear regression analysis for correlation data; and (4) the Ridit analysis for ranked data. Results were presented as means ± standard deviation (SD), and differences were considered as significant at p < 0.05 or very significant at p < 0.01.
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